HopeStage
Back to all studies
TerminatedNCT04183205

Predicting SSRI Efficacy in Veterans With PTSD

Medication studyAges 18–75United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 75 years.

Listed locations
Boston and 1 more locationSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 11, 2019
Recruitment status
Terminated
Enrollment listed in the registry
19
Sponsor
VA Office of Research and Development
Sponsor type
Government agency
Study type
Drug
Intervention type
Diagnostic test, Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT04183205
Official title
Show the full official title

An Electrophysiological Predictor of SSRI Response in Veterans With PTSD

Recruitment & locations

Terminated

Boston · Charleston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is VA Office of Research and Development, a government agency.

Does this study involve medication?

Yes. The study involves medication, including Placebo and sertraline.

Who can participate?

Listed age limits: 18 years to 75 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies